An epidemic outbreak of nephrogenic systemic fibrosis in a Danish hospital

European Journal of Radiology

Volumn 66, Issue 2, 2008, Pages 187-190

  Marckmann, Peter ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Gadodiamide; Gadolinium; Hemodialysis; Renal failure

Indexed keywords

AGENTS; BIOLOGICAL ORGANS; DISEASES; GADOLINIUM; MAGNETIC RESONANCE IMAGING; PATIENT TREATMENT;

GADODIAMIDE; HEMODIALYSIS; RENAL FAILURE;

HOSPITALS;

CALCIUM; CONTRAST MEDIUM; ERYTHROPOIETIN; GADODIAMIDE; GADOLINIUM; GADOLINIUM PENTETATE; GADOVERSETAMIDE; PHOSPHATE; SODIUM THIOSULFATE;

ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL FEATURE; CONTRACTURE; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE COMPARISON; EPIDEMIC; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; LEG PAIN; MEDICAL RECORD REVIEW; MUSCLE BIOPSY; NEPHROGENIC SYSTEMIC FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; PHYSICAL DISABILITY; PLASMAPHERESIS; PRIORITY JOURNAL; PUVA; RIGIDITY; RISK ASSESSMENT; SKIN BIOPSY; SKINFOLD; STRUCTURED INTERVIEW; SWELLING; TREATMENT OUTCOME;

CASE-CONTROL STUDIES; CONTRAST MEDIA; DENMARK; DISEASE OUTBREAKS; FEMALE; FIBROSIS; GADOLINIUM DTPA; HUMANS; KIDNEY DISEASES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SKIN DISEASES;

EID: 43049112045     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2008.01.032     Document Type: Article

References (25)

1. Cowper S.E., Robin H.S., Steinberg S.M., Su L.D., Gupta S., and Leboit P.E. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356 9234 (2000) 1000-1001
2. Cowper S.E., Su L.D., Bhawan J., Robin H.S., and Leboit P.E. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 23 5 (2001) 383-393
3. Ting W.W., Stone M.S., Madison K.C., and Kurtz K. Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 139 7 (2003) 903-906
4. Levine J.M., Taylor R.A., Elman L.B., et al. Involvement of skeletal muscle in dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy). Muscle Nerve 30 5 (2004) 569-577
5. Daram S.R., Cortese C.M., and Bastani B. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review. Am J Kidney Dis 46 4 (2005) 754-759
6. Cowper S.E. Nephrogenic systemic fibrosis: the nosological and conceptual evolution of nephrogenic fibrosing dermopathy. Am J Kidney Dis 46 4 (2005) 763-765
7. Khurram M., Skov L., Rossen K., Thomsen H.S., and Marckmann P. Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients. Scand J Urol Nephrol 41 (2007) 565-566
8. Marckmann P., Skov L., Rossen K., et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17 9 (2006) 2359-2362
9. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant 21 (2006) 1104-1108
10. Thomsen H.S., Marckmann P., and Logager V.B. Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents. Cancer Imaging 7 1 (2007) 130-137
11. Thomsen H.S., Marckmann P., and Logager V.B. Enhanced computed tomography or magnetic resonance imaging: a choice between contrast medium-induced nephropathy and nephrogenic systemic fibrosis?. Acta Radiol 48 6 (2007) 593-596
12. Marckmann P., Skov L., Rossen K., Heaf J.G., and Thomsen H.S. Case-control study of gadodiamide-related nephrogenic systemic fibrosis. Nephrol Dial Transplant 22 (2007) 3174-3178
13. Swaminathan S., Ahmed I., McCarthy J.T., et al. Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy. Ann Intern Med 145 3 (2006) 234-235
14. Cowper S.E., Bucala R., and Leboit P.E. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis-setting the record straight. Semin Arthritis Rheum 35 4 (2006) 208-210
15. Marckmann P, Skov L, Rossen K, Thomsen HS. Clinical manifestations of gadodiamide-related nephrogenic systemic fibrosis. Clin Nephrol [in press].
16. Rydahl C, Thomsen HS, Marckmann P. High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a Gadolinium (Gd)-containing magnetic resonance contrast agent. Invest Radiol [in press].
17. Cowper S.E., and Boyer P.J. Nephrogenic systemic fibrosis: an update. Curr Rheumatol Rep 8 2 (2006) 151-157
18. Lauchli S., Zortea-Caflisch C., Nestle F.O., Burg G., and Kempf W. Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis. Dermatology 208 3 (2004) 278-280
19. Gilliet M., Cozzio A., Burg G., and Nestle F.O. Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis. Br J Dermatol 152 3 (2005) 531-536
20. Richmond H., Zwerner J., Kim Y., and Fiorentino D. Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis. Arch Dermatol 143 8 (2007) 1025-1030
21. Yerram P., Saab G., Karuparthi P.R., Hayden M.R., and Khanna R. Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure-role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate. Clin J Am Soc Nephrol 2 2 (2007) 258-263
22. Swartz R.D., Crofford L.J., Phan S.H., Ike R.W., and Su L.D. Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure. Am J Med 114 7 (2003) 563-572
23. Boyd A.S., Zic J.A., and Abraham J.L. Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 56 1 (2007) 27-30
24. Thakral C., Alhariri J., and Abraham J.L. Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications. Contrast Media Mol Imaging 2 4 (2007) 199-205
25. Abraham J, Thakral C, Skov L, Rossen K, Marckmann P. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis. Br J Dermatol [in press].